Cypress Capital Advisors, LLC Merck & Co., Inc. Transaction History
Cypress Capital Advisors, LLC
- $160 Billion
- Q2 2025
A detailed history of Cypress Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cypress Capital Advisors, LLC holds 9,599 shares of MRK stock, worth $825,418. This represents 0.48% of its overall portfolio holdings.
Number of Shares
9,599
Previous 9,694
0.98%
Holding current value
$825,418
Previous $870 Million
12.67%
% of portfolio
0.48%
Previous 0.6%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,842Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.2 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.61 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.07 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $218B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...